2025-04-012026-03-312026-03-31false14295323CAS MEDICAL SERVICES LIMITED2026-07-08falseiso4217:GBPxbrli:pure142953232025-03-31142953232026-03-31142953232025-04-012026-03-31142953232024-03-31142953232025-03-31142953232024-04-012025-03-3114295323bus:SmallEntities2025-04-012026-03-3114295323bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3114295323bus:FullAccounts2025-04-012026-03-3114295323bus:PrivateLimitedCompanyLtd2025-04-012026-03-3114295323core:WithinOneYear2026-03-3114295323core:AfterOneYear2026-03-3114295323core:WithinOneYear2025-03-3114295323core:AfterOneYear2025-03-3114295323core:ShareCapital2026-03-3114295323core:SharePremium2026-03-3114295323core:RevaluationReserve2026-03-3114295323core:OtherReservesSubtotal2026-03-3114295323core:RetainedEarningsAccumulatedLosses2026-03-3114295323core:ShareCapital2025-03-3114295323core:SharePremium2025-03-3114295323core:RevaluationReserve2025-03-3114295323core:OtherReservesSubtotal2025-03-3114295323core:RetainedEarningsAccumulatedLosses2025-03-3114295323core:LandBuildings2026-03-3114295323core:PlantMachinery2026-03-3114295323core:Vehicles2026-03-3114295323core:FurnitureFittings2026-03-3114295323core:OfficeEquipment2026-03-3114295323core:NetGoodwill2026-03-3114295323core:IntangibleAssetsOtherThanGoodwill2026-03-3114295323core:ListedExchangeTraded2026-03-3114295323core:UnlistedNon-exchangeTraded2026-03-3114295323core:LandBuildings2025-03-3114295323core:PlantMachinery2025-03-3114295323core:Vehicles2025-03-3114295323core:FurnitureFittings2025-03-3114295323core:OfficeEquipment2025-03-3114295323core:NetGoodwill2025-03-3114295323core:IntangibleAssetsOtherThanGoodwill2025-03-3114295323core:ListedExchangeTraded2025-03-3114295323core:UnlistedNon-exchangeTraded2025-03-3114295323core:LandBuildings2025-04-012026-03-3114295323core:PlantMachinery2025-04-012026-03-3114295323core:Vehicles2025-04-012026-03-3114295323core:FurnitureFittings2025-04-012026-03-3114295323core:OfficeEquipment2025-04-012026-03-3114295323core:NetGoodwill2025-04-012026-03-3114295323core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3114295323core:ListedExchangeTraded2025-04-012026-03-3114295323core:UnlistedNon-exchangeTraded2025-04-012026-03-3114295323core:MoreThanFiveYears2025-04-012026-03-3114295323core:Non-currentFinancialInstruments2026-03-3114295323core:Non-currentFinancialInstruments2025-03-3114295323dpl:CostSales2025-04-012026-03-3114295323dpl:DistributionCosts2025-04-012026-03-3114295323core:LandBuildings2025-04-012026-03-3114295323core:PlantMachinery2025-04-012026-03-3114295323core:Vehicles2025-04-012026-03-3114295323core:FurnitureFittings2025-04-012026-03-3114295323core:OfficeEquipment2025-04-012026-03-3114295323dpl:AdministrativeExpenses2025-04-012026-03-3114295323core:NetGoodwill2025-04-012026-03-3114295323core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3114295323dpl:GroupUndertakings2025-04-012026-03-3114295323dpl:ParticipatingInterests2025-04-012026-03-3114295323dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3114295323core:ListedExchangeTraded2025-04-012026-03-3114295323dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3114295323core:UnlistedNon-exchangeTraded2025-04-012026-03-3114295323dpl:CostSales2024-04-012025-03-3114295323dpl:DistributionCosts2024-04-012025-03-3114295323core:LandBuildings2024-04-012025-03-3114295323core:PlantMachinery2024-04-012025-03-3114295323core:Vehicles2024-04-012025-03-3114295323core:FurnitureFittings2024-04-012025-03-3114295323core:OfficeEquipment2024-04-012025-03-3114295323dpl:AdministrativeExpenses2024-04-012025-03-3114295323core:NetGoodwill2024-04-012025-03-3114295323core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114295323dpl:GroupUndertakings2024-04-012025-03-3114295323dpl:ParticipatingInterests2024-04-012025-03-3114295323dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114295323core:ListedExchangeTraded2024-04-012025-03-3114295323dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114295323core:UnlistedNon-exchangeTraded2024-04-012025-03-3114295323core:NetGoodwill2026-03-3114295323core:IntangibleAssetsOtherThanGoodwill2026-03-3114295323core:LandBuildings2026-03-3114295323core:PlantMachinery2026-03-3114295323core:Vehicles2026-03-3114295323core:FurnitureFittings2026-03-3114295323core:OfficeEquipment2026-03-3114295323core:AfterOneYear2026-03-3114295323core:WithinOneYear2026-03-3114295323core:ListedExchangeTraded2026-03-3114295323core:UnlistedNon-exchangeTraded2026-03-3114295323core:ShareCapital2026-03-3114295323core:SharePremium2026-03-3114295323core:RevaluationReserve2026-03-3114295323core:OtherReservesSubtotal2026-03-3114295323core:RetainedEarningsAccumulatedLosses2026-03-3114295323core:NetGoodwill2025-03-3114295323core:IntangibleAssetsOtherThanGoodwill2025-03-3114295323core:LandBuildings2025-03-3114295323core:PlantMachinery2025-03-3114295323core:Vehicles2025-03-3114295323core:FurnitureFittings2025-03-3114295323core:OfficeEquipment2025-03-3114295323core:AfterOneYear2025-03-3114295323core:WithinOneYear2025-03-3114295323core:ListedExchangeTraded2025-03-3114295323core:UnlistedNon-exchangeTraded2025-03-3114295323core:ShareCapital2025-03-3114295323core:SharePremium2025-03-3114295323core:RevaluationReserve2025-03-3114295323core:OtherReservesSubtotal2025-03-3114295323core:RetainedEarningsAccumulatedLosses2025-03-3114295323core:NetGoodwill2024-03-3114295323core:IntangibleAssetsOtherThanGoodwill2024-03-3114295323core:LandBuildings2024-03-3114295323core:PlantMachinery2024-03-3114295323core:Vehicles2024-03-3114295323core:FurnitureFittings2024-03-3114295323core:OfficeEquipment2024-03-3114295323core:AfterOneYear2024-03-3114295323core:WithinOneYear2024-03-3114295323core:ListedExchangeTraded2024-03-3114295323core:UnlistedNon-exchangeTraded2024-03-3114295323core:ShareCapital2024-03-3114295323core:SharePremium2024-03-3114295323core:RevaluationReserve2024-03-3114295323core:OtherReservesSubtotal2024-03-3114295323core:RetainedEarningsAccumulatedLosses2024-03-3114295323core:AfterOneYear2025-04-012026-03-3114295323core:WithinOneYear2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114295323core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3114295323core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3114295323core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3114295323core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3114295323core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3114295323core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3114295323core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3114295323core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3114295323core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3114295323core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114295323core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114295323core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114295323core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114295323core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114295323core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114295323core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114295323core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114295323core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114295323bus:Director12025-04-012026-03-3114295323bus:Director22025-04-012026-03-31

CAS MEDICAL SERVICES LIMITED

Registered Number
14295323
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

CAS MEDICAL SERVICES LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

COUZENS, Christopher John
COUZENS, Sarah Elizabeth

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

14295323 (England and Wales)
CAS MEDICAL SERVICES LIMITED
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets31,390859
1,390859
Current assets
Debtors43,844623
Cash at bank and on hand94,31771,573
98,16172,196
Creditors amounts falling due within one year5(20,407)(21,216)
Net current assets (liabilities)77,75450,980
Total assets less current liabilities79,14451,839
Net assets79,14451,839
Capital and reserves
Called up share capital150150
Profit and loss account78,99451,689
Shareholders' funds79,14451,839
The financial statements were approved and authorised for issue by the Board of Directors on 8 July 2026, and are signed on its behalf by:
COUZENS, Christopher John
Director
Registered Company No. 14295323
CAS MEDICAL SERVICES LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Office Equipment50
2.Average number of employees

20262025
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 April 251,1991,199
Additions1,2991,299
At 31 March 262,4982,498
Depreciation and impairment
At 01 April 25340340
Charge for year768768
At 31 March 261,1081,108
Net book value
At 31 March 261,3901,390
At 31 March 25859859
4.Debtors: amounts due within one year

2026

2025

££
Other debtors3,844623
Total3,844623
5.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables527407
Taxation and social security9,1408,055
Other creditors9,24211,284
Accrued liabilities and deferred income1,4981,470
Total20,40721,216